Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States

By sjmartinez • March 18, 2025

Sisk BA, Eng W, Aye J, Mack J, Tran A, Ogino J, Pearson E, Bies J, Smink G, Shah SD, Mohney L, Fassel H, Schulte R, Chang VY, Tessem RA, Hogeling M, Swaminathan N, McLean TW, Blatt J, Alturky S, Wu M, Atkinson A, Al-Huniti A, Massey G, Engel E, Ricci K, Echols T, Kumar S, Fox M, King KA. Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States. Pediatr Blood Cancer. 2025 Mar 17:e31661. doi: 10.1002/pbc.31661. Epub ahead of print. PMID: 40091541.

Tags: Dermatology, DGSOM Student, disparities, Publications, sociodemographics, vascular malformation

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial

Mease PJ, Chandran V, Armstrong AW, Blanco R, Ogdie A, Siegel EL, Gottlieb AB, Zeng X, Thaçi D, Kishimoto M, Schulze-Koops H, Kivitz A, Dokoupilová[...]

ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype

Assan F, Tragin M, Marella S, Lipecka J, Roger K, Zarhrate M, Bondet V, Nguyen V, Akroun F, Nitschké P, Guerrera IC, Bole C, Izmiryan[...]

A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score

Cortes JA, Aflatooni S, Ure A, Palma G, Johnsen N, Smart K, Nong Y, Armstrong AW. A practical inflammatory blood-cell marker for cardiovascular risk stratification[...]